These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 10627857)

  • 21. [Renoparenchymal hypertension].
    Mühlhauser I; Sawicki P; Berger M
    Dtsch Med Wochenschr; 1989 Apr; 114(17):689-90. PubMed ID: 2707137
    [No Abstract]   [Full Text] [Related]  

  • 22. Renin-angiotensin system inhibitors in proteinuric chronic kidney disease.
    Hirsch S
    Compr Ther; 2009; 35(2):91-5. PubMed ID: 19618757
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antihypertensive therapy and the progression of chronic renal disease. Are there renoprotective drugs?
    Tolins JP; Raij L
    Semin Nephrol; 1991 Sep; 11(5):538-48. PubMed ID: 1745881
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hypertension in chronic renal failure. Treatment with hemodialysis and nephrectomy.
    Lazarus JM; Hampers C; Merrill JP
    Arch Intern Med; 1974 Jun; 133(6):1059-66. PubMed ID: 4597951
    [No Abstract]   [Full Text] [Related]  

  • 25. Treatment of chronic proteinuric kidney disease: what next?
    Benigni A; Remuzzi G
    Hypertension; 2009 Jul; 54(1):29-31. PubMed ID: 19506097
    [No Abstract]   [Full Text] [Related]  

  • 26. Blood pressure-independent reduction in proteinuria and arterial stiffness after acute endothelin-a receptor antagonism in chronic kidney disease.
    Dhaun N; Macintyre IM; Melville V; Lilitkarntakul P; Johnston NR; Goddard J; Webb DJ
    Hypertension; 2009 Jul; 54(1):113-9. PubMed ID: 19506099
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Slowing down chronic renal failure progression with various antihypertensive agents.
    Jovanović DB; Djukanović L; Naumović R
    Clin Nephrol; 1998 Dec; 50(6):390-2. PubMed ID: 9877115
    [No Abstract]   [Full Text] [Related]  

  • 28. [Hypertension in predialysis chronic renal insufficiency-- when and how to treat?].
    Switalski M
    Pol Arch Med Wewn; 2003 Oct; 110(4):1197-207. PubMed ID: 14699679
    [No Abstract]   [Full Text] [Related]  

  • 29. Renal protection in hypertensive patients: selection of antihypertensive therapy.
    Wenzel RR
    Drugs; 2005; 65 Suppl 2():29-39. PubMed ID: 16398060
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Antihypertensive therapy and progression of renal failure].
    Mann J; Ritz E
    Fortschr Med; 1987 Dec; 105(36):709-12. PubMed ID: 3428834
    [No Abstract]   [Full Text] [Related]  

  • 31. [Organ protection by antihypertensive treatment. Also conceivable for kidney diseases?. Interview by Dr. med. Monika Flasnoecker].
    Mann J
    Fortschr Med; 1996 Nov; 114(32):15. PubMed ID: 9064261
    [No Abstract]   [Full Text] [Related]  

  • 32. Strategies to retard the progression of chronic kidney disease.
    Zandi-Nejad K; Brenner BM
    Med Clin North Am; 2005 May; 89(3):489-509. PubMed ID: 15755464
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Selections from the current literature. A simplified approach to the management of early chronic renal failure.
    Kopes-Kerr CP
    Fam Pract; 2002 Oct; 19(5):563-5. PubMed ID: 12356713
    [No Abstract]   [Full Text] [Related]  

  • 34. Renoprotection by blockade of the renin-angiotensin-aldosterone system in diabetic and non-diabetic chronic kidney disease. Specific involvement of intra-renal angiotensin-converting enzyme activity in therapy resistance?
    Vogt L; Kocks MJ; Laverman GD; Navis G
    Minerva Med; 2004 Oct; 95(5):395-409. PubMed ID: 15467515
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The antihypertensive effect of verapamil in patients with chronic renal failure.
    Rodicio JL; Alcazar JM; Ruilope LM
    J Hum Hypertens; 1992 Dec; 6 Suppl 2():S41-3. PubMed ID: 1289513
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [May medical therapy of arterial hypertension by used in patients with renal failure?].
    Richet G; Ducrot H; Hamburger J; Legrain M; Maxwell M; Péquignot MH
    Presse Med (1893); 1968 Nov; 76(44):2103-6. PubMed ID: 5701039
    [No Abstract]   [Full Text] [Related]  

  • 37. Antihypertensive and antiproteinuric efficacy of ramipril in children with chronic renal failure.
    Wühl E; Mehls O; Schaefer F;
    Kidney Int; 2004 Aug; 66(2):768-76. PubMed ID: 15253732
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Progressive renal failure. Why blood pressure must now be monitored].
    Tepel M; van der Giet M; Zidek W
    MMW Fortschr Med; 2000 Jun; 142(25):42-4. PubMed ID: 10920669
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of angiotensin II receptor blockade on renal disease progression in patients with non-diabetic chronic renal failure.
    Mora-Macía J; Cases A; Calero F; Barceló P
    Nephrol Dial Transplant; 2001; 16 Suppl 1():82-4. PubMed ID: 11369829
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Hypertension as a risk factor for progression of renal failure].
    Hilgers KF; Veelken R; Luft FC; Geiger H; Mann J
    Internist (Berl); 1992 Aug; 33 Suppl 1():S27-30. PubMed ID: 1428693
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.